126 related articles for article (PubMed ID: 11598459)
1. Development of a homogeneous high throughput fluorescence polarization assay for G protein-coupled receptor binding.
Lee PH; Bevis DJ
J Biomol Screen; 2000 Dec; 5(6):415-19. PubMed ID: 11598459
[TBL] [Abstract][Full Text] [Related]
2. Use of fluorescence polarization detection for the measurement of fluopeptidetm binding to G protein-coupled receptors.
Gagne A; Banks P; Hurt SD
J Recept Signal Transduct Res; 2002; 22(1-4):333-43. PubMed ID: 12503625
[TBL] [Abstract][Full Text] [Related]
3. Homogeneous fluorescence anisotropy-based assay for characterization of ligand binding dynamics to GPCRs in budded baculoviruses: the case of Cy3B-NDP-α-MSH binding to MC4 receptors.
Veiksina S; Kopanchuk S; Mazina O; Link R; Lille A; Rinken A
Methods Mol Biol; 2015; 1272():37-50. PubMed ID: 25563175
[TBL] [Abstract][Full Text] [Related]
4. Impact of a red-shifted dye label for high throughput fluorescence polarization assays of G protein-coupled receptors.
Banks P; Gosselin M; Prystay L
J Biomol Screen; 2000 Oct; 5(5):329-34. PubMed ID: 11080691
[TBL] [Abstract][Full Text] [Related]
5. Determination of equilibrium dissociation constants in fluorescence polarization.
Prystay L; Gosselin M; Banks P
J Biomol Screen; 2001 Jun; 6(3):141-50. PubMed ID: 11689110
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence anisotropy assay for pharmacological characterization of ligand binding dynamics to melanocortin 4 receptors.
Veiksina S; Kopanchuk S; Rinken A
Anal Biochem; 2010 Jul; 402(1):32-9. PubMed ID: 20302839
[TBL] [Abstract][Full Text] [Related]
7. Budded baculoviruses as a tool for a homogeneous fluorescence anisotropy-based assay of ligand binding to G protein-coupled receptors: the case of melanocortin 4 receptors.
Veiksina S; Kopanchuk S; Rinken A
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):372-81. PubMed ID: 24095674
[TBL] [Abstract][Full Text] [Related]
8. Development of a homogeneous high-throughput live-cell G-protein-coupled receptor binding assay.
Lee PH; Miller SC; van Staden C; Cromwell EF
J Biomol Screen; 2008 Sep; 13(8):748-54. PubMed ID: 18460694
[TBL] [Abstract][Full Text] [Related]
9. Development of a facile method for high throughput screening with reporter gene assays.
Goetz AS; Andrews JL; Littleton TR; Ignar DM
J Biomol Screen; 2000 Oct; 5(5):377-84. PubMed ID: 11080697
[TBL] [Abstract][Full Text] [Related]
10. A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor.
Huwiler KG; De Rosier T; Hanson B; Vogel KW
Assay Drug Dev Technol; 2010 Jun; 8(3):356-66. PubMed ID: 20233092
[TBL] [Abstract][Full Text] [Related]
11. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
[TBL] [Abstract][Full Text] [Related]
12. Considerations for using fluorescence polarization in the screening of G protein-coupled receptors.
Banks P; Harvey M
J Biomol Screen; 2002 Apr; 7(2):111-7. PubMed ID: 12006109
[TBL] [Abstract][Full Text] [Related]
13. The expression of recombinant human LOX-1 and identifying its mimic ligands by fluorescence polarization-based high throughput screening.
Zhang T; Huang Z; Dai Y; Chen X; Zhu P; Du G
J Biotechnol; 2006 Oct; 125(4):492-502. PubMed ID: 16735073
[TBL] [Abstract][Full Text] [Related]
14. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays.
Parker GJ; Law TL; Lenoch FJ; Bolger RE
J Biomol Screen; 2000 Apr; 5(2):77-88. PubMed ID: 10803607
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence Anisotropy-Based Assay for Characterization of Ligand Binding Dynamics to GPCRs: The Case of Cy3B-Labeled Ligands Binding to MC
Veiksina S; Tahk MJ; Laasfeld T; Link R; Kopanchuk S; Rinken A
Methods Mol Biol; 2021; 2268():119-136. PubMed ID: 34085265
[TBL] [Abstract][Full Text] [Related]
16. Multiparameter analysis of a screen for progesterone receptor ligands: comparing fluorescence lifetime and fluorescence polarization measurements.
Marks BD; Qadir N; Eliason HC; Shekhani MS; Doering K; Vogel KW
Assay Drug Dev Technol; 2005 Dec; 3(6):613-22. PubMed ID: 16438657
[TBL] [Abstract][Full Text] [Related]
17. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
18. Analogs of lactam derivatives of alpha-melanotropin with basic and acidic residues.
Bednarek MA; MacNeil T; Kalyani RN; Tang R; Van der Ploeg LH; Weinberg DH
Biochem Biophys Res Commun; 2000 May; 272(1):23-8. PubMed ID: 10872798
[TBL] [Abstract][Full Text] [Related]
19. Early evaluation of compound QT prolongation effects: a predictive 384-well fluorescence polarization binding assay for measuring hERG blockade.
Deacon M; Singleton D; Szalkai N; Pasieczny R; Peacock C; Price D; Boyd J; Boyd H; Steidl-Nichols JV; Williams C
J Pharmacol Toxicol Methods; 2007; 55(3):238-47. PubMed ID: 17141530
[TBL] [Abstract][Full Text] [Related]
20. Potent and selective agonists of alpha-melanotropin (alphaMSH) action at human melanocortin receptor 5; linear analogs of alpha-melanotropin.
Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
Peptides; 2007 May; 28(5):1020-8. PubMed ID: 17376561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
